Astellas Pharma, Inc.


  • 1m
  • 3m
  • 6m
  • 1y
  • 2y
  • 5y
Mar 29, 2017
Prev close: 1,505
Mar 29, 2017
Market cap:
Market cap(USD):
Shares: 2,153.82M

Currency in JPY

Company profile

Market(Ticker): TKS(4503)
Health Technology
Pharmaceuticals: Other
Full time employees: 17,217

Business summary

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. The firm's global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.

In the news

Financial highlights

Mar 2016

  • Local currency
  • US Dollar
Revenue 1,372.70B
Gross profit 994,723M
Operating income 269,638M
Income before tax 263,013M
Net income 193,687M
EBITDA 338,826M
Diluted EPS 89.62
Dividends per share 32
Total assets 1,799.33B
Total liabilities 540,129M
Total equity 1,259.20B
Operating cash flow 316,534M

Currency in JPY

Revenue 11,431.18M
Gross profit 8,283.53M
Operating income 2,245.40M
Income before tax 2,190.23M
Net income 1,612.92M
EBITDA 2,821.56M
Diluted EPS 0.74
Dividends per share 0.26
Total assets 16,009.05M
Total liabilities 4,805.63M
Total equity 11,203.42M
Operating cash flow 2,635.93M

Currency in USD

Valuation measures

Mar 2016

PER 16.67
ROA 10.78%
ROE 15.03%
Operating margin 19.64%
Profit margin 14.10%

Key executive

  • President, CEO & Representative Director: Yoshihiko Hatanaka
  • Chief Financial Officer: Yasumasa Masuda
  • Senior Executive Officer & President-Technology: Mitsunori Matsuda
  • Representative Director & Executive Vice President: Yoshiro Miyokawa
  • Executive Officer: Masatoshi Kuroda

Share holders

  • Asset Management One Co., Ltd.(5.1%)
  • Nomura Asset Management Co., Ltd.(3.5%)
  • Astellas Pharma, Inc.(3.4%)
  • Nippon Life Insurance Co.(2.9%)
  • The Vanguard Group, Inc.(2.0%)
  • Fidelity Management & Research Co.(1.9%)
  • Nikko Asset Management Co., Ltd.(1.7%)
  • International Value Advisers LLC(1.7%)
  • Daiwa Asset Management Co. Ltd.(1.6%)
  • Wellington Management Co. LLP(1.6%)


  • Website:
  • Address: 2-5-1 Nihonbashi-Honcho, Chuo-Ku, Tokyo, 103-8411, Japan
  • Phone: +81.3.3244.3000

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.